(XERS) Xeris Pharmaceuticals Monthly charts technical analysis
(XERS) Xeris Pharmaceuticals Monthly charts technical analysis Monthly analysis of Xeris Pharmaceuticals | Buy/Sell Xeris Pharmaceuticals
Xeris Pharmaceuticals trades in USA in Health Care sector.
10 day averaged volume of Xeris Pharmaceuticals is 4267200
Date | Closing Price | Open | High | Low | Volume |
08 Tue Apr 2025 | 4.13 | 5.48 | 5.50 | 4.09 | 22.764 Mn |
31 Mon Mar 2025 | 5.49 | 3.85 | 5.97 | 3.59 | 79.07 Mn |
28 Fri Feb 2025 | 3.83 | 3.48 | 4.10 | 3.45 | 34.304 Mn |
31 Fri Jan 2025 | 3.56 | 3.39 | 3.78 | 3.14 | 32.67 Mn |
31 Tue Dec 2024 | 3.39 | 3.69 | 3.75 | 3.17 | 20.165 Mn |
26 Tue Nov 2024 | 3.18 | 3.26 | 3.64 | 2.82 | 35.639 Mn |
31 Thu Oct 2024 | 3.22 | 2.85 | 3.39 | 2.69 | 27.707 Mn |
30 Mon Sep 2024 | 2.85 | 2.79 | 3.04 | 2.48 | 36.435 Mn |
30 Fri Aug 2024 | 2.81 | 2.49 | 2.94 | 2.10 | 36.153 Mn |
31 Wed Jul 2024 | 2.48 | 2.24 | 2.67 | 2.03 | 26.129 Mn |
Indicators analysis of Xeris Pharmaceuticals (XERS)
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Xeris Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Xeris Pharmaceuticals in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Xeris Pharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Xeris Pharmaceuticals in short term but SELL signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Xeris Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.75 and Xeris Pharmaceuticals (XERS) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Xeris Pharmaceuticals (XERS) stock. Volume based technical analysis of Xeris Pharmaceuticals (XERS) stock is negative.
Xeris Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Monthly charts
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Xeris Pharmaceuticals ( (XERS) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Xeris Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Xeris Pharmaceuticals in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Xeris Pharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Xeris Pharmaceuticals in short term but SELL signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Xeris Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.75 and Xeris Pharmaceuticals (XERS) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Xeris Pharmaceuticals (XERS) stock. Volume based technical analysis of Xeris Pharmaceuticals (XERS) stock is negative.
Xeris Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.